Find Reports

Select Report Type

Reimbursement Review

Displaying 476 - 500 of 1258

Please scroll or swipe to the right to view the full content.

Brand Name	Generic Name	Files	Therapeutic Area	Recommendation Type	Status	Submission Date	Recommendation Date Sort ascending	Project Number
Keytruda	Pembrolizumab	pcodr_provfund_pembrolizumab_keytruda_MUC.pdf pcodr_pembrolizumab_keytruda_muc_fn_rec.pdf pcodr_pembrolizumab_keytruda_muc_fn_cgr.pdf pcodr_pembrolizumab_keytruda_muc_fn_egr.pdf pcodr_pembrolizumab_keytruda_muc_in_rec.pdf pcodr_pembrolizumab_keytruda_muc_pagfdk.pdf pcodr_pembrolizumab_keytruda_muc_fdk_merck.pdf pcodr_pembrolizumab_keytruda_muc_clnfdk.pdf pcodr_pembrolizumab_keytruda_muc_coi_pt.pdf pcodr_pembrolizumab_keytruda_muc_coi_cln.pdf	For locally advanced or metastatic urothelial carcinoma	Reimburse with clinical criteria and/or conditions	Complete	Jul 24, 2017	Mar 2, 2018	PC0117-000
Venclexta	Venetoclax	pcodr_profund_venetoclax_venclexta_cll.pdf pcodr_venetoclax_venclexta_cll_fn_rec.pdf pcodr_venetoclax_venclexta_cll_fn_cgr.pdf pcodr_venetoclax_venclexta_cll_fn_egr.pdf pcodr_venetoclax_venclexta_cll_in_rec.pdf pcodr_venetoclax_venclexta_cll_pagfdk.pdf pcodr_venetoclax_venclexta_cll_fdk_abbvie.pdf pcodr_venetoclax_venclexta_cll_ptfdk.pdf pcodr_venetoclax_venclexta_cll_clnfdk.pdf pcodr_venetoclax_venclexta_cll_coi_pt.pdf pcodr_venetoclax_venclexta_cll_coi_cln.pdf	Chronic Lymphocytic Leukemia	Reimburse with clinical criteria and/or conditions	Complete	Jul 10, 2017	Mar 2, 2018	PC0105-000
Tremfya	guselkumab	TS0001-PsO-Updated-Streamlined-Rec.pdf SR0530_Tremfya_complete_Feb-23-18.pdf SR0530_Tremfya_CL_Report.pdf SR0530_Tremfya_PE_Report.pdf SR0530_Tremfya_PI_Submissions.pdf	Psoriasis, moderate to severe plaque	Reimburse with clinical criteria and/or conditions	Complete	Aug 25, 2017	Feb 21, 2018	SR0530-000
Orfadin	nitisinone	SR0531_Orfadin_complete_Feb-23-18.pdf SR0531_Orfadin_CL_Report.pdf SR0531_Orfadin_PE_Report.pdf SR0531_Orfadin_PI.pdf	Hereditary tyrosinemia type 1	Reimburse with clinical criteria and/or conditions	Complete	Aug 29, 2017	Feb 21, 2018	SR0531-000
Adcetris	Brentuximab Vedotin	pcodr_profund_brentuximab_adcetris_hl_post-asct_resub.pdf pcodr_brentuximab_adcetris_hl_post-asct_resub_fn_rec.pdf pcodr_brentuximab_adcetris_hl_post-asct_resub_fn_cgr.pdf pcodr_brentuximab_adcetris_hl_post-asct_resub_fn_egr.pdf pcodr_brentuximab_adcetris_hl_post-asct_resub_in_rec.pdf pcodr_brentuximab_adcetris_hl_post-asct_resub_pagfdk.pdf pcodr_brentuximab_adcetris_hl_post-asct_resub_fdk_sgi.pdf pcodr_brentuximab_adcetris_hl_post-asct_resub_clnfdk.pdf pcodr_brentuximab_adcetris_hl_post-asct_resub_coi_pt.pdf pcodr_brentuximab_adcetris_hl_post-asct_resub_coi_cln.pdf	HL at high risk of relapse or progression post-ASCT	Reimburse with clinical criteria and/or conditions	Complete	Aug 10, 2017	Feb 21, 2018	PC0116-000
Renflexis	infliximab	TS0001-PsO-Updated-Streamlined-Rec.pdf SE0532 Renflexis - CDEC Final Recommendation February 20, 2018(redacted)_for posting.pdf SE0532_Renflexis_Combined_Report.pdf SE0532_Renflexis_PI.pdf	rheumatoid arthritis, ankylosing spondylitis, adult Crohn’s disease, pediatric Crohn’s disease, fistulising Crohn’s disease, adult ulcerative colitis, pediatric ulcerative colitis, psoriatic arthritis, plaque psoriasis	Reimburse with clinical criteria and/or conditions	Complete	Sep 5, 2017	Feb 20, 2018	SE0532-000
Faslodex	Fulvestrant	pcodr_provfund_fulvestrant_faslodex_mbc.pdf pcodr_fulvestrant_faslodex_mbc_fn_rec.pdf pcodr_fulvestrant_faslodex_mbc_fn_cgr.pdf pcodr_fulvestrant_faslodex_mbc_fn_egr.pdf pcodr_fulvestrant_faslodex_mbc_in_rec.pdf pcodr_fulvestrant_faslodex_mbc_pagfdk.pdf pcodr_fulvestrant_faslodex_mbc_fdk_asz.pdf pcodr_fulvestrant_faslodex_mbc_ptfdk.pdf pcodr_fulvestrant_faslodex_mbc_clnfdk.pdf pcodr_fulvestrant_faslodex_mbc_coi_pt.pdf pcodr_fulvestrant_faslodex_mbc_coi_cln.pdf	Locally advanced or metastatic breast cancer	Reimburse with clinical criteria and/or conditions	Complete	Jul 17, 2017	Feb 1, 2018	PC0110-000
Galafold	migalastat	SR0522_Galafold_complete_Jan-26-18.pdf SR0522_Galafold_CL_Report.pdf SR0522_Galafold_PE_Report.pdf SR0522_Galafold_Patient_Input.pdf	Fabry Disease	Reimburse with clinical criteria and/or conditions	Complete	Jun 9, 2017	Jan 24, 2018	SR0522-000
Procysbi	cysteamine bitartrate	SR0526_Procysbi_complete_Jan-26-18.pdf SR0526_Procysbi_CL_Report.pdf SR0526_Procysbi_PE_Report.pdf SR0526_Procysbi_Patient_Input.pdf SI0002-procysbi-drug-implementation-advice.pdf	Nephropathic cystinosis	Reimburse with clinical criteria and/or conditions	Complete	Aug 8, 2017	Jan 24, 2018	SR0526-000
Vosevi	sofosbuvir velpatasvir voxilaprevir	SR0529_Vosevi_complete_Jan-25-18.pdf SR0529_Vosevi_CL_Report.pdf SR0529_Vosevi_PE_Report.pdf SR0529 Vosevi_Patient_Input.pdf	Hepatitis C, chronic	Reimburse with clinical criteria and/or conditions	Complete	Jul 28, 2017	Jan 23, 2018	SR0529-000
Maviret	glecaprevir pibrentasvir	SR0523_Maviret_complete-Jan-25-18.pdf SR0523_Maviret_CL_Report.pdf SR0523_Maviret_PE_Report.pdf SR0523_Maviret_Patient_Input.pdf	Hepatitis C, chronic	Reimburse with clinical criteria and/or conditions	Complete	Jun 9, 2017	Jan 23, 2018	SR0523-000
Movapo	apomorphine hydrochloride	SR0527_Movapo_complete-Jan-25-18.pdf SR0527_Movapo_CL_Report.pdf SR0527_Movapo_PE_Report.pdf SR0527_Movapo_Patient_Input.pdf	Parkinson's disease	Reimburse with clinical criteria and/or conditions	Complete	Jul 6, 2017	Jan 23, 2018	SR0527-000
Onivyde	Irinotecan Liposome	pcodr_provfund_irinotecan_liposome_onivyde_mpc.pdf pcodr_irinotecan_liposome_onivyde_mpc_fn_rec.pdf pcodr_irinotecan_liposome_onivyde_mpc_fn_cgr.pdf pcodr_irinotecan_liposome_onivyde_mpc_fn_egr.pdf pcodr_irinotecan_liposome_onivyde_mpc_in_rec.pdf pcodr_irinotecan_liposome_onivyde_mpc_pagfdk.pdf pcodr_irinotecan_liposome_onivyde_mpc_clnfdk.pdf pcodr_irinotecan_liposome_onivyde_mpc_coi_pt.pdf pcodr_irinotecan_liposome_onivyde_mpc_coi_cln.pdf	Metastatic Pancreatic Cancer	Reimburse with clinical criteria and/or conditions	Complete	Apr 27, 2017	Jan 5, 2018	PC0107-000
Keytruda	Pembrolizumab	pcodr_profund_pembrolizumab_keytruda_chl.pdf pcodr_pembrolizumab_keytruda_chl_fn_rec.pdf pcodr_pembrolizumab_keytruda_chl_fn_cgr.pdf pcodr_pembrolizumab_keytruda_chl_fn_egr.pdf pcodr_pembrolizumab_keytruda_chl_in_rec.pdf pcodr_pembrolizumab_keytruda_chl_pagfdk.pdf pcodr_pembrolizumab_keytruda_chl_fdk_merck.pdf pcodr_pembrolizumab_keytruda_chl_ptfdk.pdf pcodr_pembrolizumab_keytruda_chl_clnfdk.pdf pcodr_pembrolizumab_keytruda_chl_coi_pt.pdf pcodr_pembrolizumab_keytruda_chl_coi_cln.pdf	classical Hodgkin Lymphoma (cHL)	Reimburse with clinical criteria and/or conditions	Complete	Jul 7, 2017	Jan 5, 2018	PC0109-000
Spinraza	nusinersen	SR0525_Spinraza_complete_Dec_22_17.pdf SR0525_Spinraza_CL_Report.pdf SR0525_Spinraza_PE_Report.pdf SR0525_Spinraza_Patient_Input.pdf	Spinal Muscular Atrophy	Reimburse with clinical criteria and/or conditions	Complete	Jun 28, 2017	Dec 22, 2017	SR0525-000
Rydapt	Midostaurin	pcodr_profund_midostaurin_rydapt_aml.pdf pcodr_midostaurin_rydapt_all_fn_rec.pdf pcodr_midostaurin_rydapt_all_fn_cgr.pdf pcodr_midostaurin_rydapt_all_fn_egr.pdf pcodr_midostaurin_rydapt_all_in_rec.pdf pcodr_midostaurin_rydapt_all_pagfdk.pdf pcodr_midostaurin_rydapt_all_fdk_novartis.pdf pcodr_midostaurin_rydapt_all_clnfdk.pdf pcodr_midostaurin_rydapt_all_coi_pt.pdf pcodr_midostaurin_rydapt_all_coi_cln.pdf	Acute Myeloid Leukemia	Reimburse	Complete	Jun 12, 2017	Dec 19, 2017	PC0108-000
Opdivo & Yervoy in combo	Nivolumab & Ipilimumab in combo	pcodr_profund_opdivo_yervoy_metmela.pdf pcodr_opdivo_yervoy_metmela_fn_rec.pdf pcodr_opdivo_yervoy_metmela_fn_cgr.pdf pcodr_opdivo_yervoy_metmela_fn_egr.pdf pcodr_opdivo_yervoy_metmela_in_rec.pdf pcodr_opdivo_yervoy_metmela_pagfdk.pdf pcodr_opdivo_yervoy_metmela_fdk_bms.pdf pcodr_opdivo_yervoy_metmela_ptfdk_mnc.pdf pcodr_opdivo_yervoy_metmela_ptfdk_sys.pdf pcodr_opdivo_yervoy_metmela_clfdk.pdf pcodr_opdivo_yervoy_metmela_coi_pt.pdf pcodr_opdivo_yervoy_metmela_coi_cl.pdf	Metastatic Melanoma	Reimburse with clinical criteria and/or conditions	Complete	Nov 30, 2016	Nov 30, 2017	PC0098-000
Adlyxine	lixisenatide	SR0520_Adlyxine_complete_Nov-23-17.pdf SR0520_Adlyxine_CL_Report.pdf SR0520_Adlyxine_PE_Report.pdf SR0520_Adlyxine_PI_Submissions.pdf	Diabetes mellitus, Type 2	Reimburse with clinical criteria and/or conditions	Complete	May 29, 2017	Nov 23, 2017	SR0520-000
Repatha	Evolocumab	cdr_SR0515_Repatha.pdf SR0515_Repatha_Resubmission_complete_Nov_24_17.pdf SR0515_Repatha_Resubmission_CL_Report.pdf SR0515_Repatha_Resubmission_PE_Report.pdf SR0515_Repatha_PI_Submissions.pdf	Primary hyperlipidemia and mixed dyslipidemia	Reimburse with clinical criteria and/or conditions	Complete	Feb 17, 2017	Nov 22, 2017	SR0515-000
Fibristal	ulipristal acetate	SF0528_Fibristal_RFA_complete_Nov_22_17.pdf SF0528_Fibristal_RFA_Report.pdf SF0528_Fibristal_PI_Submissions.pdf	Uterine fibroids (signs and symptoms)	Reimburse with clinical criteria and/or conditions	Complete	Jun 21, 2017	Nov 22, 2017	SF0528-000
Rexulti	Brexpiprazole	cdr_SR0514_TBC.pdf SR0514_Rexulti_complete_Nov_24_17.pdf SR0514_Rexulti_CL_Report.pdf SR0514_Rexulti_PE_Report.pdf SR0514_Rexulti_PI_Submissions.pdf	schizophrenia	Reimburse with clinical criteria and/or conditions	Complete	Feb 3, 2017	Nov 22, 2017	SR0514-000
Ocrevus	ocrelizumab	SR0519_Ocrevus_RMS_complete_Nov-23-17.pdf SR0519_Ocrevus_RMS _PE_Report.pdf SR0519_Ocrevus_RMS_CL_Report.pdf SR0519_Ocrevus_RMS_PI_Submissions.pdf	multiple sclerosis, relapsing	Reimburse with clinical criteria and/or conditions	Complete	May 16, 2017	Nov 21, 2017	SR0519-000
Tresiba	insulin degludec	SR0521_Tresiba_complete_Nov-22-17_e.pdf SR0521_Tresiba_CL_Report.pdf SR0521_Tresiba_PE_Report.pdf SR0521_Tresiba_PI_Submissions.pdf	Diabetes mellitus, Type 1 & 2	Reimburse with clinical criteria and/or conditions	Complete	May 31, 2017	Nov 20, 2017	SR0521-000
Tafinlar & Mekinist in combo	Dabrafenib & Trametinib in combo	pcodr_provfund_tafinlar_mekinist_nsclc.pdf pcodr_tafinlar_mekinist_nsclc_fn_rec.pdf pcodr_tafinlar_mekinist_nsclc_fn_cgr.pdf pcodr_tafinlar_mekinist_nsclc_fn_egr.pdf pcodr_tafinlar_mekinist_nsclc_in_rec.pdf pcodr_tafinlar_mekinist_nsclc_pagfdk.pdf pcodr_tafinlar_mekinist_nsclc_fdk_novartis.pdf pcodr_tafinlar_mekinist_nsclc_ptfdk.pdf pcodr_tafinlar_mekinist_nsclc_clfdk.pdf pcodr_tafinlar_mekinist_nsclc_coi-cl.pdf pcodr_tafinlar_mekinist_nsclc_coi-pt.pdf	Non-Small Cell Lung Cancer	Do not reimburse	Complete	Mar 31, 2017	Nov 2, 2017	PC0106-000
Izba	travoprost ophthalmic solution	cdr_SR0516_Izba.pdf SR0516_Izba_complete_Oct-30-17.pdf SR0516_Izba_CL_Report.pdf SR0516_Izba_PE_Report.pdf	Glaucoma and ocular hypertension	Reimburse with clinical criteria and/or conditions	Complete	Mar 1, 2017	Oct 25, 2017	SR0516-000

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 476 - 500 of 589

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Sub Line	Status	Project Number
Injectable Opioid Agonist Treatment for Patients with Opioid Dependence: A Review of Clinical and Cost-Effectiveness	RC1277-iOAT Final.pdf	Jun 2, 2020	Summary with Critical Appraisal	Completed	RC1277-000
Ketamine for Chronic Non-Cancer Pain: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines	RC1281 - Ketamine for CNCP Final.pdf	Jun 2, 2020	Summary with Critical Appraisal	Completed	RC1281-000
Nasal Decolonization for the Prevention of Surgical Site Infections: A Review of Clinical Effectiveness and Cost-Effectiveness	RC1278 Nasal Decolonization Clinical and Cost Upgrade Final.pdf	May 28, 2020	Summary with Critical Appraisal		RC1278-000
Adalimumab for Adult Patients with Crohn’s Disease: A Review of Clinical Effectiveness	RC1272 Adalimumab for Crohns Final.pdf	May 14, 2020	Summary with Critical Appraisal		RC1272-000
Tools		May 14, 2020
External Supports for the Treatment of Ankle Sprain: A Review of Clinical Effectiveness	RC1263 External Supports Ankle Sprain Final.pdf	May 7, 2020	Summary with Critical Appraisal	Completed	RC1263-000
Comparative Assessment of Coverage Criteria for Biologic Disease-Modifying Antirheumatic Drugs Across Canadian Public Drug Plans: An Environmental Scan		May 5, 2020	Environmental Scan	Completed	ES0351-000
Pharmacological Interventions for Chronic Pain in Pediatric Patients: A Review of Guidelines	RC1275 Ped Chronic Pain Guidelines Final.pdf	May 5, 2020	Summary with Critical Appraisal	Completed	RC1275-000
Vein Illumination Devices in Long-Term and Acute Care Settings: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines	RC1268 Vein Illumination Devices Final.pdf	May 4, 2020	Summary with Critical Appraisal		RC1268-000
Islet Cell Transplantation for Patients with Unstable or Uncontrollable Diabetes Mellitus: Clinical Effectiveness. Cost-Effectiveness and Guidelines	RC1270- ICT Final.pdf	May 4, 2020	Summary with Critical Appraisal	Completed	RC1270-000
Transanal Total Mesorectal Excision for Adult Patients with Rectal Cancer: A Review of Clinical Effectiveness and Cost-Effectiveness	RC1271 TaTME Final.pdf	May 4, 2020	Summary with Critical Appraisal	Completed	RC1271-000
Primary Care Initiated Gender-Affirming Therapy for Gender Dysphoria: A Review of Evidence Based Guidelines	RC1267 Primary Care Initiated GAT for GD Final.pdf	May 1, 2020	Summary with Critical Appraisal	Completed	RC1267-000
Pleuroscopy for the Diagnosis of Cancer in Patients with Pleural Effusion: A Review of the Diagnostic Accuracy, Safety, Cost-Effectiveness and Guidelines	RC1260 Pleuroscopy Final.pdf	Apr 27, 2020	Summary with Critical Appraisal	Completed	RC1260-000
Psychotherapy for the Treatment of Acute Musculoskeletal Pain: A Review of Clinical Effectiveness and Guidelines	RC1262 Psychotherapy Acute Pain Final.pdf	Apr 27, 2020	Summary with Critical Appraisal	Completed	RC1262-000
Non-invasive Nerve Stimulation Modalities for Migraine Pain: A Review of Clinical Effectiveness and Cost-effectiveness	RC1265 NINS for Migraine Final.pdf	Apr 27, 2020	Summary with Critical Appraisal	Completed	RC1265-000
Epinephrine Auto-Injectors for Anaphylaxis: A Review of the Clinical Effectiveness, Cost-Effectiveness, and Guidelines	RC1269 Epinephrine Auto-Injector Final.pdf	Apr 27, 2020	Summary with Critical Appraisal	Completed	RC1269-000
Customized or Prefabricated Shoe Inserts for Chronic, Non-Cancer Pain: A Review of Clinical Effectiveness	RC1259 Orthotics Pain Final.pdf	Apr 20, 2020	Summary with Critical Appraisal	Completed	RC1259-000
Harmonization of Public Coverage Policies for Biologic Drugs in the Treatment of Rheumatoid Arthritis	Optimal Use 360 Report Utilization Review Budget Impact Analysis	Apr 17, 2020		Complete	HD0001-000
Skin Preparation for Injections: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines	RC1218 Skin Prep Injection Final corrected.pdf	Apr 16, 2020	Summary with Critical Appraisal	Completed	RC1218-000
Exercise for the Treatment of Ankle Sprain: A Review of Clinical Effectiveness and Guidelines	RC1261 - Exercise ankle sprain Final.pdf	Apr 13, 2020	Summary with Critical Appraisal	Completed	RC1261-000
Bacille Calmette-Guérin Vaccination: A Review of Clinical Effectiveness and Guidelines	RC1264 BCG Vaccination Final.pdf	Apr 6, 2020	Summary with Critical Appraisal	Completed	RC1264-000
Masks for Prevention of Influenza Transmission in Acute and Long-Term Care Settings: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines	RC1255 Influenza Masks Final.pdf	Mar 31, 2020	Summary with Critical Appraisal	Completed	RC1255-000
Intravitreal Dexamethasone Implants for Non-infectious Uveitis: A Review of Clinical Effectiveness, Cost-effectiveness, and Guidelines	RC1257-000 Ozurdex Uveitis Final.pdf	Mar 31, 2020	Summary with Critical Appraisal	Completed	RC1257-000
Body Weight Modification Interventions for Chronic Non-Cancer Pain: A Review of Clinical Effectiveness	RC1258 Weight change pain Final.pdf	Mar 31, 2020	Summary with Critical Appraisal	Completed	RC1258-000
Serial X-Ray Radiography for the Diagnosis of Osteomyelitis: A Review of Diagnostic Accuracy, Clinical Utility, Cost-Effectiveness, and Guidelines	RC1256 Serial Radiography Osteomyelitis Final.pdf	Mar 23, 2020	Summary with Critical Appraisal	Completed	RC1256-000

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 111 of 111

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 40 of 40

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 476 - 500 of 2093

Please scroll or swipe to the right to view the full content.

Title	Description	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
Routine Dental Polishing for Oral Health		Routine Dental Polishing for Oral Health	Nov 8, 2023	Health Technology Review	Rapid Review	Completed	RC1517-000
Intrathecal Drug Delivery Systems for Cancer Pain			Nov 6, 2023	Health Technology Review	Technology Review	Completed	HC0058-000
Buprenorphine Naloxone Film versus Tablets for Opioid Use Disorder	CADTH's Health Technology Review identifies and summarizes literature comparing the effectiveness and cost-effectiveness of sublingual buprenorphine-naloxone films versus tablets.	Buprenorphine Naloxone Film versus Tablets for Opioid Use Disorder	Nov 6, 2023	Health Technology Review	Rapid Review	Completed	RC1513-000
Intraocular Lenses for Cataract Surgery		Intraocular Lenses for Cataract Surgery	Nov 6, 2023	Health Technology Review	Rapid Review	Completed	RC1515-000
Anti–Vascular Endothelial Growth Factor Drugs for Age-Related Macular Degeneration		Anti–Vascular Endothelial Growth Factor Drugs for Age-Related Macular Degeneration	Nov 6, 2023	Health Technology Review	Rapid Review	Completed	RC1510-000
Supplemental Screening Modalities for People With Dense Breasts			Nov 1, 2023	Health Technology Review	Technology Review	Completed	HC0026-000
Chronic Lymphocytic Leukemia		Final Report	Oct 27, 2023	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0035-000
Prostate Cancer		Final Report	Oct 27, 2023	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0034-000
ravulizumab		Recommendation and Reasons Clinical, Pharmacoeconomic and Ethics combined Report Stakeholder feedback on Draft Recommendation	Oct 27, 2023	Reimbursement Review		Complete	SR0765-000
Hyperbaric Oxygen Therapy: An Emerging Therapy for Post–COVID-19 Condition	CADTH’s Horizon Scan examines hyperbaric oxygen therapy as a treatment to help resolve prominent symptoms of post-COVID-19 condition, such as fatigue and brain fog.	Hyperbaric Oxygen Therapy: An Emerging Therapy for Post–COVID-19 Condition	Oct 27, 2023	Horizon Scan	Health Technology Update	Completed	EN0050-000
Refractive Laser Surgery for Vision Conditions		Refractive Laser Surgery for Vision Conditions	Oct 26, 2023	Health Technology Review	Rapid Review	Completed	RC1514-000
New and Emerging Interventions to Alleviate Emergency Department Overcrowding	CADTH's Horizon Scan captures more than 80 new and emerging interventions to alleviate emergency department overcrowding. The interventions are organized into 5 broad categories of factors that contribute to emergency department overcrowding.	New and Emerging Interventions to Alleviate Emergency Department Overcrowding	Oct 25, 2023	Horizon Scan	Health Technology Update	Completed	EN0051-000
deucravacitinib		Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Oct 25, 2023	Reimbursement Review		Complete	SR0756-000
brentuximab vedotin			Oct 25, 2023	Reimbursement Review		Withdrawn	PC0311-000
avacopan		Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Oct 20, 2023	Reimbursement Review		Complete	SR0732-000
Cost-Effectiveness of Nirsevimab for Prevention of Respiratory Syncytial Virus Outcomes in Infants		Cost-Effectiveness of Nirsevimab for Prevention of Respiratory Syncytial Virus …	Oct 19, 2023	Health Technology Review	Technology Review	Completed	HE0045-000
Semaglutide 2 mg for Type 2 Diabetes		Semaglutide 2 mg for Type 2 Diabetes	Oct 19, 2023	Health Technology Review	Rapid Review	Completed	RC1507-000
Point of Care Ultrasound for Guided Central Venous Catheter Insertion		Point of Care Ultrasound for Guided Central Venous Catheter Insertion	Oct 16, 2023	Health Technology Review	Rapid Review	Completed	RC1509-000
Post–COVID-19 Condition Treatment and Management: Rapid Living Scoping Review			Oct 12, 2023	Health Technology Review	Scoping Review	Living Review	RE0040-000/RE0040-004
Radiofrequency Ablation for Chronic Knee, Hip, and Shoulder Pain		Radiofrequency Ablation for Chronic Knee, Hip, and Shoulder Pain	Oct 11, 2023	Health Technology Review	Rapid Review	Completed	RC1504-000
IV Acetaminophen for Acute Pain in Emergency Departments		IV Acetaminophen for Acute Pain in Emergency Departments	Oct 6, 2023	Health Technology Review	Rapid Review	Completed	RC1508-000
Drug Shortages in Canada — Expert Panel			Oct 5, 2023	Health Technology Review	Technology Review	In Progress	HC0074-000
Perspectives and Experiences Regarding the Impacts of Emergency Department Overcrowding		Perspectives and Experiences Regarding the Impacts of Emergency Department Over…	Sep 28, 2023	Health Technology Review	Technology Review	Completed	HC0067-000
CADTH Pharmaceutical Reviews Update — Issue 41			Sep 28, 2023	Reimbursement Review	Pharmaceutical Review Update
rimegepant			Sep 27, 2023	Reimbursement Review		Withdrawn	SR0797-000